Cytotherapy

Cytotherapy

  • Volume 1
  • Issue 12
  • ISSN 1465-3249
  • SCImago Journal Rank (SJR): 1.192
  • Source Normalized Impact per Paper (SNIP): 0.991
  • Impact Factor: 5.414
  • Five Year Impact Factor: 4.97
Editor-in-chief:

Subscription options

Sales tax will be calculated at check-out
Subscription length
Print - Rolling Subscription
Next planned ship date: May 03, 2021

Description

Cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials on emerging trends and potential controversies in the field, and Review articles summarizing important areas of cell and gene therapy research that are topical and/or challenge existing paradigms in the field.

Cytotherapy considers manuscripts exploring the following topics:

  • Development and/or characterization of novel gene therapies and cell and/or EV-based therapeutics
  • Design of novel therapeutic approaches employing cell/EV/gene products.
  • Mode of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.
  • Identification of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.
  • Role of stem/stromal cells and/or EVs in disease pathophysiology.
  • Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.
  • Important advances in cell/EV/gene-based product manufacturing and validation
  • Global/regional regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.


Cytotherapy does not publish manuscripts on the following topics:

  • Case studies unless they are of unusual significance to the field.
  • Basic/translational studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology
  • Studies describing signaling pathways implicated in cancer

Product details

  • SCImago Journal Rank (SJR): 1.192
  • Source Normalized Impact per Paper (SNIP): 0.991
  • Impact Factor: 5.414
  • Five Year Impact Factor: 4.97
  • ISSN: 1465-3249
  • Issues: 12
  • Volume: 1
Editorial board

Author services

Prepare your article for submission

Celebrate your publication

Additional services

Publication schedule

Issue volumeIssue yearPlanned ship dateActual ship date
23/12021Jan 08, 2021Jan 05, 2021
23/22021Jan 25, 2021Jan 22, 2021
23/32021Mar 03, 2021Feb 26, 2021
23/42021Mar 25, 2021Mar 26, 2021
23/4S2021May 03, 2021
23/52021May 04, 2021May 07, 2021
23/5S2021May 26, 2021May 10, 2021
23/62021May 17, 2021May 21, 2021
23/72021Jun 25, 2021Jun 24, 2021
23/82021Jul 23, 2021Jul 23, 2021
23/92021Aug 24, 2021Aug 25, 2021
23/102021Sep 24, 2021Sep 21, 2021
23/112021Oct 27, 2021
23/122021Nov 24, 2021
24/12022Jan 04, 2022
24/22022Jan 25, 2022
24/32022Feb 22, 2022
24/42022Mar 22, 2022
24/52022Apr 22, 2022
24/62022May 23, 2022
24/72022Jun 21, 2022
24/82022Jul 22, 2022
24/92022Aug 22, 2022
24/102022Sep 22, 2022
24/112022Oct 21, 2022
24/122022Nov 21, 2022